Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX10059 for acute treatment of migraine
2006-001488-51Phase 2Completed
- Sponsor
- Addex Therapeutics Ltd
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing ADX10059 with Placebo (2 arms). Primary endpoint: Efficacy of ADX10059 on acute migraine headache pain. Started Jun 2006; status: completed.
02
Drugs
raseglurant
03
Conditions
migraine
Beyond the preview
Go deeper on 2006-001488-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001488-51.